- recruiting
Pilot Study on the Validity of the Metacognitive Hub Model of Craving in Bulimia Nervosa (BN) and Binge Eating Disorders (BED)
This study looks at powerful urges to eat (cravings) in women with bulimia nervosa and binge eating disorder. It will explore how different parts of the mind connect with these cravings and why some people might feel them more strongly, with the aim of better understanding these eating challenges.
Canada · France - recruiting
Compuls-BED-Severity
This study looks at Binge Eating Disorder (BED) to better understand how severe it can be. We want to find clearer ways to tell the difference between mild and severe BED, especially in people who are also obese. This could help doctors offer better care.
Canada - active not recruitingNA
Efficacy of Juniver, a Digital Self-help Intervention, on Symptoms of Eating Disorders: A Randomised Controlled Trial
This study is testing a new iPhone app called Juniver for people with eating disorders. It's a digital self-help program with tools, learning, and peer support. Researchers want to see if it helps reduce eating disorder symptoms and improves well-being.
United Kingdom - enrolling by invitationNA
Effectiveness of Group EFT for Transdiagnostic Eating Disorders/Difficulties Within Student Counselling Services.
This study looks at how well group therapy called Emotion-Focused Therapy (EFT) works for students with eating problems at university counselling services. We want to see if it's a good way to help students feel better and improve their mental health.
United Kingdom - enrolling by invitationNA
Preparing for Eating Disorders Treatment Through Compassionate Letter-Writing
This study looks at how writing self-compassionate letters might help people with eating disorders prepare for treatment. It involves two weeks of letter writing before starting a longer group therapy program, aiming to improve recovery rates for conditions like anorexia and bulimia.
Canada - ongoing, recruitingHuman Pharmacology (Phase I)- Other
Open label, single-center, two-part pharmacokinetic study: Part I: Relative bioavailability study to compare the pharmacokinetics of BP1.4979 after administration of single oral doses of BP1.4979 as sustained release formulation and actual immediate release formulation, under fasting and fed conditions, in healthy subjects. Part II: Pharmacokinetics of BP1.4979 after a 14-day dosing period with b.i.d. administration of BP1.4979 as sustained release formulation in healthy subjects.
This study looks at how a new medicine, BP1.4979, works in healthy people. We want to see how the body absorbs, uses, and gets rid of the medicine when taken in different ways, specifically if it's a slow-release tablet or a quick-release one.
Belgium - ongoing, recruitingTherapeutic exploratory (Phase II)
A double-blind, placebo-controlled pilot trial of BP1.4979 for the treatment of binge eating disorder.
This study is testing a new medicine, BP1.4979, for binge eating disorder. It compares the new medicine to a dummy pill to see if it reduces how often people binge eat. We want to find out if this medicine could help people manage their condition better.
France · Spain - ongoing, recruitingTherapeutic exploratory (Phase II)
Glucocorticoid enhancement of food exposure therapy in Binge Eating Disorder
This study is looking into whether a medication called hydrocortisone can help reduce strong cravings for food in people with Binge Eating Disorder. It aims to see if participants feel less craving when faced with real food a few days after treatment.
Germany